Wordt geladen...
Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
PURPOSE: Intradetrusor onabotulinum toxin A (BTXA) and sacral neuromodulation (SNM) are effective third-line therapies for overactive bladder (OAB). We aimed to measure the outcomes of BTXA for treatment of OAB refractory to initial SNM and identify patient characteristics associated with these outc...
Bewaard in:
| Gepubliceerd in: | Int Neurourol J |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Korean Continence Society
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6790822/ https://ncbi.nlm.nih.gov/pubmed/31607102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5213/inj.1938030.015 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|